NRXS logo

NEURAXIS INC

NRXSNYSE AMERICAN
🏆 #4134 by market capEarnings Nov 11US Equity
$7.71▲ $0.21 (+2.66%)
After hours · at close
🔔
Track NRXS
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 2.7%
7d▲ 4.3%
14d▲ 33.4%
30d▲ 28.9%
ytd▲ 71.3%
1y▲ 145.5%
🏦Market Cap
$95M
Small Cap
📈Revenue Growth (YoY)
+65.2%
High Growth
📊Gross Margin
85.5%
High
💵FCF Margin
—
⚖️P/S Ratio
17.9x
Expensive
Otter Score
76
Good

Trading Snapshot

Day Range
$7.61 – $7.83
52-Week Range
$2.21 – $9.33
Volume
$3.58B
Avg Volume
$4.65B
Shares Outstanding
12.4M
Next Earnings
Nov 5, 2026

Fundamentals Snapshot

Annual Revenue
$5M
Last Q Revenue
$1M
P/E Ratio
—
P/S Ratio
17.9x
EPS (TTM)
$-0.71
Dividend Yield
—
Dilution (1yr)
+31.3%

Why Investors Own NRXS

  • ✓High-growth profile — revenue up +55.0% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 77% gross margin and 17% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

NRXS logo

NEURAXIS INC

NRXS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$4M▲ +32.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
84.2%▼ −2.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$8M▲ +9.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$6M▲ +5.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
9.1M▲ +31.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$5M▲ +$1M YoY
StockOtter · stockotter.space

About NEURAXIS INC

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
76/100

Analyst Ratings

ⓘ
Consensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

🚀
MarketWatch·2h ago

NEURAXIS INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Bloomberg·5h ago

Analysts lift NRXS price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Bloomberg·1d ago

NEURAXIS INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.